X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
dose-intense temozolomide (24) 24
humans (23) 23
index medicus (23) 23
oncology (19) 19
glioblastoma (16) 16
phase-ii trial (15) 15
malignant glioma (14) 14
aged (13) 13
female (13) 13
glioblastoma multiforme (13) 13
male (13) 13
middle aged (13) 13
temozolomide (13) 13
clinical neurology (12) 12
treatment outcome (12) 12
adult (11) 11
bevacizumab (11) 11
brain neoplasms - drug therapy (10) 10
glioblastoma - drug therapy (10) 10
adjuvant temozolomide (9) 9
brain neoplasms - therapy (9) 9
dacarbazine - analogs & derivatives (9) 9
single-agent bevacizumab (9) 9
glioblastoma - therapy (8) 8
care and treatment (7) 7
chemotherapy (7) 7
neoplasm recurrence, local - drug therapy (7) 7
newly-diagnosed glioblastoma (7) 7
prognosis (7) 7
radiation-therapy (7) 7
recurrent glioblastoma (7) 7
glioblastoma - mortality (6) 6
glioblastoma - pathology (6) 6
medicine & public health (6) 6
therapy (6) 6
aged, 80 and over (5) 5
antineoplastic agents, alkylating - therapeutic use (5) 5
brain neoplasms - diagnosis (5) 5
brain neoplasms - mortality (5) 5
brain neoplasms - pathology (5) 5
dacarbazine - administration & dosage (5) 5
neurology (5) 5
retrospective studies (5) 5
survival (5) 5
young adult (5) 5
analysis (4) 4
angiogenesis (4) 4
antineoplastic agents - therapeutic use (4) 4
combined modality therapy (4) 4
dacarbazine - therapeutic use (4) 4
disease-free survival (4) 4
endothelial growth-factor (4) 4
glioblastoma - diagnosis (4) 4
glioma (4) 4
high-grade glioma (4) 4
neoplasm recurrence, local - mortality (4) 4
promoter methylation (4) 4
surgery (4) 4
survival analysis (4) 4
610 medicine & health (3) 3
abridged index medicus (3) 3
angiogenesis inhibitors (3) 3
antibodies, monoclonal, humanized - therapeutic use (3) 3
antimitotic agents (3) 3
antineoplastic agents (3) 3
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
bevacizumab plus irinotecan (3) 3
brain neoplasms - metabolism (3) 3
cancer (3) 3
clinic for neurology (3) 3
clinical trials (3) 3
disease progression (3) 3
dna methylation (3) 3
dna modification methylases - genetics (3) 3
dna repair enzymes - genetics (3) 3
drug therapy (3) 3
glioblastoma - metabolism (3) 3
health aspects (3) 3
hematology, oncology and palliative medicine (3) 3
high-grade gliomas (3) 3
irinotecan (3) 3
methylation (3) 3
mgmt (3) 3
multiforme (3) 3
neoplasm recurrence, local - pathology (3) 3
neoplasm recurrence, local - therapy (3) 3
o-6-methylguanine-dna methyltransferase (3) 3
patients (3) 3
phase-ii (3) 3
prognostic-factors (3) 3
randomized-trial (3) 3
recurrent (3) 3
recurrent malignant glioma (3) 3
tumor suppressor proteins - genetics (3) 3
angiogenesis inhibitors - therapeutic use (2) 2
animals (2) 2
antineoplastic agents - adverse effects (2) 2
antineoplastic combined chemotherapy protocols - administration & dosage (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
bevacizumab - administration & dosage (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer, ISSN 0008-543X, 03/2012, Volume 118, Issue 5, pp. 1302 - 1312
Journal Article
Brain, ISSN 0006-8950, 12/2015, Volume 138, Issue 12, pp. 3654 - 3672
Journal Article
Current Oncology Reports, ISSN 1523-3790, 04/2019, Volume 21, Issue 4, p. 1
Purpose of ReviewTemozolomide is a first-line treatment for newly diagnosed glioblastoma. In this review, we will examine the use of temozolomide in other... 
Pilocytic astrocytoma | Low grade glioma | Temozolomide | DIPG | Ependymoma | GBM in the elderly | Bevacizumab | Pleomorphic xanthoastrocytoma | DOSE-INTENSE TEMOZOLOMIDE | LONG-TERM | CONCURRENT RADIOTHERAPY | BRAIN-STEM GLIOMAS | ADJUVANT TEMOZOLOMIDE | CHILDREN | PHASE-II TRIAL | THERAPY | ONCOLOGY | ELDERLY-PATIENTS | Chemotherapy | Evidence-based medicine | Glioblastoma multiforme | Cancer
Journal Article
Neuro-Oncology, ISSN 1522-8517, 07/2013, Volume 15, Issue 7, pp. 930 - 935
Journal Article
Neuro-Oncology, ISSN 1522-8517, 01/2013, Volume 15, Issue 1, pp. 4 - 27
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 10/2017, Volume 80, Issue 4, pp. 715 - 721
Journal Article
Journal Article
Neuro-Oncology, ISSN 1522-8517, 2014, Volume 16, Issue 9, pp. 1255 - 1262
Journal Article